title: Enhanced monocyte tissue factor response after experimental balloon angioplasty in hypercholesterolemic rabbit: inhibition with dietary L-arginine.
abstract: BACKGROUND
  There is evidence that tissue factor (TF) is a major contributor to the thrombogenicity of a ruptured atherosclerotic plaque. Nitric oxide (NO) has antiatherogenic and antithrombotic properties. We investigated whether L-arginine (L-arg), the endogenous precursor of NO, might affect the ability of monocytes to produce TF.
  
  
  RESULTS
  We studied TF expression in 18 rabbits with atherosclerosis induced by bilateral iliac damage and 10 weeks of a 2% cholesterol diet. Six weeks after the initiation of the diet, an angioplasty was performed. After angioplasty, the surviving rabbits (n=15) were randomized to receive L-arg (2.25%) supplementation in drinking water (L-arg group, n=8) or no treatment (untreated group, n=7). TF expression was evaluated in mononuclear cells from arterial blood in the presence and absence of endotoxin stimulation. Monocyte TF expression, as assessed with an amidolytic assay, did not differ significantly before or after the induction of atherosclerotic lesions (87+/-15 versus 70+/-12 mU of TF/1000 monocytes, P=NS). Endotoxin-stimulated TF activity increased significantly 4 weeks after angioplasty (138+/-22 versus 70+/-12 mU of TF/1000 monocytes, P=0.02). This increase was blunted by L-arg (43+/-16 mU of TF/1000 monocytes, P=0.01).
  
  
  CONCLUSIONS
  This study demonstrates that angioplasty-induced plaque rupture is associated with a marked increase in monocyte TF response that is blunted by the oral administration of L-arg. This suggests that the documented antithrombotic properties of NO may be related in part to an inhibitory effect on monocyte TF response.
authors.affiliation: Laboratoire d'Hématologie, Service de Cardiologie et Hémodynamique, Cedex, France.
authors.forename: D
authors.initials: D
authors.lastname: Corseaux
authors.forename: T
authors.initials: T
authors.lastname: Le Tourneau
authors.forename: I
authors.initials: I
authors.lastname: Six
authors.forename: M D
authors.initials: MD
authors.lastname: Ezekowitz
authors.forename: E P
authors.initials: EP
authors.lastname: Mc Fadden
authors.forename: T
authors.initials: T
authors.lastname: Meurice
authors.forename: P
authors.initials: P
authors.lastname: Asseman
authors.forename: C
authors.initials: C
authors.lastname: Bauters
authors.forename: B
authors.initials: B
authors.lastname: Jude
mesh_terms: D000800:Angioplasty, Balloon; D000818:Animals; D001120:Arginine / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000628:therapy*; D004032:Diet; D006937:Hypercholesterolemia / Q000097:blood*; D007958:Leukocyte Count / Q000187:drug effects; D008055:Lipids / Q000097:blood; D008297:Male; D009000:Monocytes / Q000378:metabolism*; D010976:Platelet Count / Q000187:drug effects; D011817:Rabbits; D013925:Thromboplastin / Q000378:metabolism*
chemical_list: D008055:Lipids; D013925:Thromboplastin; D001120:Arginine